Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
An analysis of Medicare patient procedural data by Dr. Charles .M. Intenzo, a nuclear physician at Thomas Jefferson University in Philadelphia found that radiology’s share of procedures involving the administration of radioiodine dropped 7% from 1996 to 2007. At the same time, the number of procedures administered by endocrinologists jumped by nearly one-third (32%).
The total number of such procedures covered by Medicare Part B remained stable over the 10-year period. Medicare covered 13,273 procedures requiring radioiodine in 1996. The total in 2007 was 13,004.
Endocrinology practice revolves around a limited number of applications, so practitioners are naturally attracted to these procedures as a new source of income. Regulatory barriers to their involvement have fallen as the Department of Energy has watered down the minimum training requirements for isotope handling and administration, Intenzo said.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.